Purple Biotech Ltd. (PPBT) DCF Valuation

Purple Biotech Ltd. (PPBT) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Purple Biotech Ltd. (PPBT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Purple Biotech Ltd. (PPBT) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and examine how changes affect the valuation of Purple Biotech Ltd. (PPBT) – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 1.0 1.0 -.3 -.9 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 -132 184.38 -100 -25 -25 -25 -25 -25
EBITDA -6.1 -28.4 -17.5 -21.5 -22.2 .0 .0 .0 .0 .0
EBITDA, % -613.7 -2841 5473.75 2361.76 100 20 20 20 20 20
Depreciation .2 .2 .2 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 17.8 23.5 -72.19 -22.09 100 9.4 9.4 9.4 9.4 9.4
EBIT -6.3 -28.6 -17.7 -21.7 -22.4 .0 .0 .0 .0 .0
EBIT, % -631.5 -2864.5 5545.94 2383.85 100 20 20 20 20 20
Total Cash 6.4 57.8 47.2 32.1 15.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.5 .5 .0 .0 .0
Account Receivables, % 149.3 50 0 0 100
Inventories -1.5 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % -149.3 0 0 0 100 0 0 0 0 0
Accounts Payable 1.2 1.2 1.5 2.1 3.5 .0 .0 .0 .0 .0
Accounts Payable, % 124.5 119.8 -460.31 -234.29 100 20 20 20 20 20
Capital Expenditure .0 -.2 -.1 -.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -1.1 -15.6 35.94 25.05 100 -3.34 -3.34 -3.34 -3.34 -3.34
Tax Rate, % 0.48556 0.48556 0.48556 0.48556 0.48556 0.48556 0.48556 0.48556 0.48556 0.48556
EBITAT -6.5 -12.7 -18.4 -20.8 -22.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.1 -13.1 -17.5 -20.1 -20.7 -3.5 .0 .0 .0 .0
WACC, % 6.49 6.36 6.49 6.48 6.49 6.46 6.46 6.46 6.46 6.46
PV UFCF
SUM PV UFCF -3.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -14
Equity Value 11
Diluted Shares Outstanding, MM 221
Equity Value Per Share 0.05

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Purple Biotech Ltd. (PPBT) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Financial Data: Access reliable pre-loaded historical performance and future forecasts for Purple Biotech Ltd. (PPBT).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation insights.
  • Designed for All Users: A straightforward, intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Purple Biotech Ltd. (PPBT) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Purple Biotech Ltd.'s (PPBT) intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Purple Biotech Ltd. (PPBT) Calculator?

  • Accuracy: Utilizes real Purple Biotech financial data to ensure precision.
  • Flexibility: Built for users to easily adjust and test various inputs.
  • Time-Saving: Avoid the complexities of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users with varying financial backgrounds.

Who Should Use Purple Biotech Ltd. (PPBT)?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for assessing biotech investments.
  • Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the biotech sector.
  • Consultants and Advisors: Deliver precise valuation analyses for clients interested in Purple Biotech Ltd. (PPBT).
  • Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling related to biotech.
  • Biotech Enthusiasts: Gain insights into how companies like Purple Biotech Ltd. (PPBT) are valued in the investment landscape.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Purple Biotech Ltd. (PPBT) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Purple Biotech Ltd. (PPBT).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.